Improving the diffraction quality of heat-shock protein 47 crystals
Acta Crystallographica Section F Structural Biology Communications · 2024
DOI: 10.1107/s2053230x24009233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Crystallographica Section F Structural Biology Communications, 2024. Verfasst von Kevin Kish und 16 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Structure & Design, Bristol Myers Squibb Research & Development, PO Box 4000, Princeton, NJ 08543-4000, USA. Hauptthemen laut MEDLINE: HSP47 Heat-Shock Proteins, Crystallization. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Heat-shock protein 47 (HSP47) is a potential target for inhibitors that ameliorate fibrosis by reducing collagen assembly. In an effort to develop a structure-based drug-design system, it was not possible to replicate a previous literature result (PDB entry 4au4) for apo dog HSP47; instead, crystal forms were obtained in which pairs of dog HSP47 molecules interacted through a noncleavable C-terminal His-tag to build up tetramers, all of which had multiple molecules of HSP47 in the asymmetric unit and none of which diffracted as well as the literature precedent. To overcome these difficulties, a two-pronged approach was followed: (i) the His-tag was moved from the C-terminus to the N-terminus and was made cleavable, and (ii) Adnectin (derived from the tenth domain of human fibronectin type III) crystallization chaperones were developed. Both approaches provided well diffracting crystals, but the latter approach yielded crystal forms with only one or two HSP47 complexes per asymmetric unit, which made model building less onerous.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Structure & Design, Bristol Myers Squibb Research & Development, PO Box 4000, Princeton, NJ 08543-4000, USA.
- Protein Science, Bristol Myers Squibb Research & Development, PO Box 4000, Princeton, NJ 08543-4000, USA.
- Biologics & Platforms, Bristol Myers Squibb Research & Development, PO Box 4000, Princeton, NJ 08543-4000, USA.
- Discovery Biotherapeutics, Bristol Myers Squibb Research & Development, Cambridge, MA 02141, USA.
ORCID-Profile: Kevin Kish, Chunhong Yan, John A Newitt, Elizabeth Tomasco, John Haugner, Dasa Lipovšek, Bi Deng, Yihong Zhang, Steven Sheriff
Zitieren
APA
Kish, K., Cobell, S., Szapiel, N., Yan, C., Newitt, J. A., Tredup, J., Rodrigo, I., Tomasco, E., Gao, M., Marsilio, F., Haugner, J., Lipovšek, D., Deng, B., Bousquet, P., Zhang, Y., Schmidt, H., & Sheriff, S. (2024). Improving the diffraction quality of heat-shock protein 47 crystals. Acta Crystallographica Section F Structural Biology Communications. https://doi.org/10.1107/s2053230x24009233
Vancouver
Kish K, Cobell S, Szapiel N, Yan C, Newitt JA, Tredup J, et al. Improving the diffraction quality of heat-shock protein 47 crystals. Acta Crystallographica Section F Structural Biology Communications. 2024. doi:10.1107/s2053230x24009233
BibTeX
@article{Kish2024,
author = {Kish, Kevin and Cobell, Stephen and Szapiel, Nicolas and Yan, Chunhong and Newitt, John A and Tredup, Jeffrey and Rodrigo, Iyoncy and Tomasco, Elizabeth and Gao, Mian and Marsilio, Frank and Haugner, John and Lipovšek, Dasa and Deng, Bi and Bousquet, Patrick and Zhang, Yihong and Schmidt, Holly and Sheriff, Steven},
title = {Improving the diffraction quality of heat-shock protein 47 crystals},
journal = {Acta Crystallographica Section F Structural Biology Communications},
year = {2024},
doi = {10.1107/s2053230x24009233}
}
EUVIMED